“The future ain’t what it used to be”

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there is no unmet need, or the therapy fulfils a need but at a price customers are not prepared to pay.

The answer lies in future scenario planning, but when pharma companies are typically predicting market conditions and customer demand up to two decades ahead, decisions based on flawed anticipation can prove costly at many stages through the development and marketing phases.

This White Paper explains how to plan for multiple potential future scenarios, based on a clear understanding of current trends. Click the button to download the full report.